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ABSTRACT
Mitochondria change their shape through fusion and fission in order to adapt to their metabolic milieu.
Mitofusin-2 (MFN2) is a key regulatory protein in this process, mediating mitochondrial fusion and interaction
with endoplasmic reticulum. Targeted deletion of Mfn2 in oocytes resulted in mitochondrial dysfunction and
female subfertility associated with impaired oocyte maturation and follicle development. Oocytes lacking
MFN2 showed shortened telomeres and increased apoptosis, resulting in compromised oocyte quality and
accelerated follicular depletion, consistent with a reproductive aging phenotype.

INTRODUCTION
Mitochondria are double membrane-bound, motile
organelles that play a central role in several key cellular
processes, including energy production, calcium
homeostasis, and regulation of apoptosis [1].
Mitochondria have the ability to adapt their size and
shape through fusion and fission in response to changes
in their metabolic milieu [2]. Mitochondrial fusion and
fission also play a critical role in maintaining functional
mitochondria when cells experience metabolic or
environmental stress [3]. Fusion enables mixing the
contents of two mitochondria and helps mitigate stressrelated
mitochondrial
dysfunction
through
complementation [3]. Fission is primarily used to create
new mitochondria. In addition, fission acts as a quality
control mechanism by enabling the removal of damaged
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mitochondrial components and can facilitate apoptosis
at times of increased cellular stress. During mouse and
human oocyte and early embryo development,
mitochondria structure, shape, and number are tightly
controlled, suggesting an important role for these
processes in reproduction [4].
Mitofusin-1 (MFN1) and mitofusin-2 (MFN2) are
GTPases embedded in the outer mitochondrial
membrane and are essential for mitochondrial fusion. In
addition to the mitofusins, optic atrophy 1 (OPA1)
regulates inner mitochondrial membrane fusion, and
dynamin related protein 1 (DRP1) is responsible for
mitochondrial fission [5, 6]. Importantly, mitochondria
are in constant interaction with endoplasmic reticulum
(ER) [7], and this interaction helps regulate
autophagosome formation, mitochondrial fission, Ca2+
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homeostasis, and apoptosis [8, 9]. Studies in mouse
embryonic fibroblasts have demonstrated that MFN2 is
localized to the mitochondria–ER interface, where, in
addition to its role in mitochondrial fusion, it functions
to anchor mitochondria to the ER [10]. MFN2 mutations
have been detected in two neurological disorders:
Charcot-Marie-Tooth neuropathy type 2A and Axonal
Neuropathy with Optic Atrophy [12].
In mice, global germline knockout of Mfn1, Mfn2,
Opa1, and Drp1 are embryonic lethal [13-15].
Therefore, investigation of the role of these genes in
reproduction requires conditional knockout and
knockdown approaches. Oocyte-speciﬁc knockout of
mitochondrial ﬁssion factor Drp1 results in female
infertility, impaired folliculogenesis, and ovulation [16].
Knockdown of mitochondrial fusion gene Mfn2 by
siRNA in immature oocytes results in a decline in
oocyte maturation and fertilization [17] and lower
expression of Mfn2 is found in cisplatin-induced
premature ovarian failure in mice [18]. However, an
appreciation of the contribution of mitochondrial fusion
genes to adaptive responses of the reproductive system
function and aging remains to be elucidated.
In the current study, we investigated the role of MFN2
in female fertility and ovarian function. We found that
oocyte-specific targeted deletion of Mfn2 results in
impaired mitochondrial function and dynamics, leading
to subfertility associated with impaired follicle
development and oocyte maturation. Importantly,
absence of MFN2 in the oocyte causes increased
apoptosis and shortened telomere length, which results
in compromised oocyte quality and follicular depletion,
and a phenotype consistent with accelerated
reproductive aging.

RESULTS
Loss of MFN2 in oocytes results in female
subfertility associated with impaired oocyte
maturation and embryo development
We generated oocyte-specific Mfn2 knockout mice
(Mfn2fl/fl/Zp3-Cre, referred to as Mfn2-/- throughout the
manuscript for simplicity) by crossing floxed Mfn2
mice to transgenic mice expressing Zp3-Cre [19, 20],
and bred sexually mature female mice (8-week-old, n=7
for each genotype) with WT male mice (12-week-old)
of proven fertility (male: female; 1:2). During 12 weeks
period of continuous mating, Mfn2-/- mice consistently
exhibited reduced fertility compared to WT with a
significant decrease in litter size (5.3 ± 0.2 vs. 7.3 ± 0.3
pups per litter, p<0.001) and number of litters per
female (2.7 ± 0.29 vs. 3.7 ± 0.36, p<0.05) (Figure 1A).
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Both genotypes exhibited normal mating behavior and
vaginal plug formation.
Ability to generate oocytes (germinal vesicle [GV] and
metaphase II [MII]), 2-cell embryos, and blastocysts
was assessed after injection with PMSG (5IU) or PMSG
and hCG (5IU) and mating with WT males as indicated.
Mfn2-/- mice generated significantly lower number of
GV oocytes (15 ±1.1 vs 36.6 ±1.8, p<0.01), MII oocytes
(10.6 ± 1.4 vs 21.3 ± 1.2, p<0.01), 2-cell embryos (8 ±
0.5 vs 19.3 ± 0.8, p<0.001), and blastocysts (6 ± 0.5 vs
13 ± 0.5, p<0.01), compared to WT (Figure 1B).
To characterize the mechanism of impaired oocyte
maturation in Mfn2-/- mice, we performed in vitro
maturation (IVM) experiments and assessed germinal
vesicle breakdown (GVBD, which marks metaphase I),
polar body extrusion (which marks metaphase II), and
chromatin alignment and spindle morphology. After 18
h of in vitro culture, Mfn2-/- GV stage oocytes had a
lower rate of GVBD (76.2 ± 2.3 vs 91.4 ± 4.4%,
p<0.05) (Figure 1C), lower rate of first polar body
extrusion (37.4 ± 3.3 vs 74.6 ± 4.5%, p<0.01) (Figure
1D), and significantly lower proportion of normal
spindles (45.03 ± 4.1 vs 92.45 ± 1.5 %, p<0.001)
(Figure 1E and 1G). We also tested spindle morphology
of in vivo generated mature (MII) oocytes collected
from the oviduct and found that a significantly lower
number of Mfn2-/- oocytes displayed normal spindle
morphology compared to WT (60 ± 2.8, vs 89.3 ± 2.3
%, p<0.01) (Figure 1F and 1H).
Targeted deletion of Mfn2 in oocytes results in
mitochondrial dysfunction
We then characterized mitochondrial function in GV
stage Mfn2-/- oocytes. Mfn2-/- oocytes had lower levels
of ATP (0.82 ± 0.08 vs 1.31 ± 0.1 pmol, p<0.01)
(Figure 2A), and expressed decreased amounts of
mRNAs coding for electron transport chain (ETC)
complex I (Ndufv1) and V (Atp5a1) proteins (Figure
2B). In addition, Mfn2-/- oocytes had significantly
decreased membrane potential (1.02 ± 0.04 vs 1.41 ±
0.07, p<0.01) (Figure 2C and 2F), and elevated levels of
ROS compared to WT (51.72 ± 3.2 vs 35.69 ± 1.9, pixel
intensity, p < 0.01) (Figure 2D and 2G). We also found
that the mtDNA copy number were significantly lower
(56,655 ± 20,659 vs 136,268 ± 24,588, p<0.05) in Mfn2/oocytes (Figure 2E).
When we assessed mitochondria and ER distribution in
Mfn2-/- GV oocytes, we found increased perinuclear
aggregation compared to WT (25 ± 2.8 vs 94.33 ± 2.3,
p<0.01) (Figure 2H and 2I); a distribution that was
reported to be associated with diminished ATP
generation capacity [21]. Electron microscopy (EM)
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Figure 1. Subfertility, and impaired follicle, oocyte and embryo development in Mfn2-/- mice. (A) Fertility of female Mfn2-/-

(oocyte-specific Mfn2 knockout, Mfn2fl/fl/Zp3-Cre, referred to as Mfn2-/-) and WT mice (8-week-old, n = 7 for each genotype) was
assessed by mating with WT males of proven fertility (male/female; 1:2) for 12 weeks. Mfn2-/- mice had smaller litter size (pups per
litter) and litters per female compared with WT females. (B) Number of GV oocytes, MII oocytes, 2-cell embryos and blastocysts in
Mfn2-/- and WT mice. (C, D) Oocytes at GV stage were collected from PMSG-primed Mfn2-/- and WT mice and analyzed after 18 h of
culture under in vitro maturation conditions. Percentages of GVBD and of first polar body extrusion in Mfn2-/- and WT oocytes are
shown. (E, G) After 18 h of IVM, Mfn2-/- and WT MII oocytes were stained with α-tubulin and DAPI. Left column, DAPI (blue); middle
column, anti-α-tubulin antibody (green); right column, merged images of DAPI and anti-α-tubulin staining. Percentages of normal
spindle morphology in Mfn2-/- and WT MII oocytes after IVM are shown. (F, H) Mature (MII) oocytes were collected from the oviducts
of superovulated 8-week-old Mfn2-/- and WT mice and stained with α-tubulin and DAPI. Percentages of normal spindle morphology in
Mfn2-/- and WT MII oocytes are shown. Data presented as mean ± SEM. *p < 0.05, ***p < 0.0001, vs. WT using t-test.

showed mitochondria to be larger (12.91 ± 0.67 vs 4.25
± 0.12 μm2, p<0.001) and with smaller aspect ratio
(length/width) (1.45 ± 0.02 vs 1.82 ± 0.08, p<0.01) in
Mfn2-/- oocytes compared to WT (Figure 2J, 2K and
2L). Collectively, these data suggested that
mitochondrial function and dynamics are impaired in
Mfn2-/- oocytes.
www.aging-us.com
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Gene expression is altered in Mfn2-/- oocytes
To delineate the genes and pathways affected in MFN2deficient oocytes, RNA sequencing (RNAseq) analysis
was performed in GV oocytes and secondary follicle
enclosed oocytes (SFOs) derived from Mfn2-/- and WT
mice. Hierarchical clustering of the differentially
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Figure 2. Mitochondrial function is impaired in Mfn2-/- oocytes. (A) ATP measurement in Mfn2-/- and WT mice GV stage oocytes.

(B) mRNA expression of respiratory chain genes was assessed using qRT-PCR in GV stage oocytes collected from Mfn2-/- and WT mice. (C,
F) Representative fluorescent micrographs of GV stage oocytes stained by mitochondria JC-1. Red fluorescence represents J-aggregate
while green fluorescence represents JC-1 monomer. Mitochondrial membrane potential is indicated by the red/green fluorescence
intensity ratio. (D, G) Fluorescence intensity of Carboxy-H2DCFDA was used to measure ROS levels after treatment with H2O2. (E) mtDNA
copy number was determined by qRT-PCR in GV stage oocytes collected from Mfn2-/- and WT mice. (H) Mitochondria and ER were
labeled by immunostaining with MitoTracker (red) and ER-Tracker (blue). (I) The percentages of oocytes with normal distribution of
mitochondria in the Mfn2-/- and WT mice. (J) Representative electron microscopic graphs of oocytes from 8-week-old Mfn2-/- and WT
mice (n=3 ovary from different mice assessed in each group). Arrows show mitochondria. (K, L) Mitochondrial size and aspect ratio in
Mfn2-/- and WT oocytes. Data presented as mean ± SEM. *p < 0.05, **p < 0.01 vs. WT from t-test. ATP: Adenosine triphosphate. Ndufv1:
NADH dehydrogenase (ubiquinone) flavoprotein 1; Sdhb: succinate dehydrogenase complex iron sulfur subunit B; Uqcrc2: ubiquinol
cytochrome c reductase core protein 2; Cox1: cytochrome c oxidase subunit I; Atp5a1: ATP synthase, H+ transporting, mitochondrial F1
complex, alpha subunit 1.
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Figure 3. Gene expression is altered in Mfn2-/- GV stage and secondary follicle enclosed oocytes. (A, E) Heatmaps showing

differentially expressed genes in Mfn2-/- and WT GV oocytes and secondary follicle enclosed oocytes (SFO) from 8-week-old mice. The
color spectrum ranging from red color to blue color indicates normalized levels of gene expression from high to low. (B, F) Volcano
plots for RNA-seq comparing Mfn2-/- and WT GV oocytes and SFOs. Red spot represents –log10 (p-value) ≥ 2; blue spot represents the –
log10 (p-value) < 2. (C, G) Gene ontology (GO) cluster analysis of the significant over-representation of elements in Mfn2-/- and WT GV
oocytes and SFOs from 8-week-old mice. (D, H) Pathway enrichment analysis in Mfn2-/- oocytes compared to WT GV oocytes and SFOs.

expressed genes partitioned into two distinct clusters to
separate Mfn2-/- and WT GV oocytes (Figure 3A). A
total of 363 genes were significantly differentially
expressed (p<0.05) in Mfn2-/- compared to WT GV
oocytes, with 241 up-regulated and 122 down-regulated
genes (Figure 3B). Gene ontology (GO) analysis
indicated significant over-representation of elements
involved in regulation of embryonic development, cell
death and survival, and cell morphology (Figure 3C).
Most significantly regulated pathways in Mfn2-/- GV
oocytes were listed in Figure 3D. Notably, telomerase
signaling pathway and sirtuin signaling pathway were
affected (Figure 3D).
Hierarchical clustering of the differentially expressed
genes also partitioned into two distinct clusters to
separate Mfn2-/- and WT SFOs (Figure 3E). A total of
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1,041 genes were significantly differentially expressed
(p<0.05) in Mfn2-/- SFOs compared to WT, with 510 upregulated and 531 down-regulated (Figure 3F). The
biological processes significantly represented at this
comparison included regulation of cell death and
survival, cellular development and cellular growth
(Figure 3G). Pathway analysis revealed essential
regulated signaling pathways as listed in Figure 3H.
Importantly, death receptor signaling pathway,
ceramide biosynthesis and adherens junction signaling
pathway, were all affected in Mfn2-/- SFOs (Figure 3H).
Targeted deletion of Mfn2 in oocyte results in
accelerated depletion of ovarian follicular reserve
Our RNAseq analysis showed that aging-related
telomerase and sirtuin signaling pathways were
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Figure 4. Accelerated follicle depletion in Mfn2-/- mice. (A, C, E, G) Representative micrographs of 3-weeks and 2-, 6- and 12-

months old Mfn2-/- and WT mice ovary sections stained with hematoxylin and eosin. (B, D, F, H) Follicle counts in 3-weeks and 2-, 6- and
12-months old Mfn2-/- and WT mice ovaries. Data presented as mean ± SEM. *p < 0.05 vs. WT using t-test.

affected, and genes involved in cell death and survival
were differentially expressed in Mfn2-/- oocytes. We had
also found accelerated follicle depletion in mice
deficient for mitochondrial stress response gene Clpp
[22]. We therefore next characterized how the follicle
pool changes throughout mouse reproductive lifespan in
unstimulated Mfn2-/- and WT mice ovaries.
Pre-pubertal (3-week-old) Mfn2-/- and WT mice had
similar number of follicles at different stages of
development (Figure 4A and 4B). At 2 months, the
number of primordial (which represent ovarian
follicular reserve) and primary follicles did not differ
between Mfn2-/- and WT ovaries, while Mfn2-/- ovaries
had decreased number of secondary and antral follicles
(Figure 4C and 4D). By 6 months, Mfn2-/- ovaries had
significantly lower number of primordial as well as
secondary and antral follicles (Figure 4E and 4F). At 12
months (Figure 4G and 4H), Mfn2-/- ovaries showed
dramatically decreased number of follicles at all stages.
We also assessed serum levels of hormones associated
with ovarian reserve. FSH levels were increased in 2-,
6-, and 12-month-old Mfn2-/- mice compared to wild
type (Supplementary Figure 1A), and serum AMH
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levels were significantly lower in 2-, 6-, and 12-monthold Mfn2-/- mice compared to WT (Supplementary
Figure 1B). In addition, the ovaries of Mfn2-/- mice were
significantly smaller in size (1.7 ± 0.1 vs 3.5 ± 0.1 mm2
at 8-week, p<0.001; n = 5 for each genotype)
(Supplementary Figure 2A and 2B).
These results demonstrate that oocyte-specific deletion
of Mfn2 causes accelerated follicular depletion, and
results in a phenotype similar to that observed in
women with diminished ovarian reserve and in those
approaching peri-menopause.
Mfn2-/- secondary follicle-enclosed oocytes show
increased apoptosis associated with elevated levels of
ceramide and decreased expression of E-cadherin
and Connexin 37
We next sought to investigate the potential mechanisms
of accelerated follicle loss in Mfn2-/- mice. Oocyte
apoptosis results in follicular developmental arrest and
follicular atresia [23], and impaired oocyte-granulosa
cell communication may lead to oocyte apoptosis [24].
Our bioinformatics analysis revealed that apoptosis,
ceramide biosynthesis, and junction signaling pathways
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Figure 5. Increased apoptosis in Mfn2-/- secondary follicle-enclosed oocytes is associated with increased ceramide and
decreased junction protein expression. (A, C) Immunofluorescence staining of caspase-6 (green) and ceramide (green) in

secondary follicles of Mfn2-/- and WT mice ovaries. DAPI was used to stain nuclei (blue). (B, D) Quantitative analysis of caspase-6 and
ceramide immunofluorescence in secondary follicles of Mfn2-/- and WT mice ovaries. (E, G) Immunofluorescence staining of E-cadherin
(red) and Connexin37 (red) in secondary follicles of Mfn2-/- and WT mice ovaries. (F, H) Quantitative analysis of E-cadherin and
Connexin37 immunofluorescence in secondary follicles of Mfn2-/- and WT mice ovaries. Data presented as mean ± SEM. *p < 0.05 vs.
WT using t-test.

were differentially regulated in Mfn2-/- SFOs (Figure
3H). We therefore tested whether apoptosis is increased
in Mfn2-/- oocytes, and whether pathways implicated in
apoptosis-induction (ceramide biosynthesis) and oocytegranulosa cell communication (junction signaling
pathway) are indeed affected.
We found increased expression of apoptosis effector
protein caspase 6 in Mfn2-/- SFOs compared to WT
(2.19 ± 0.34 vs 1 ± 0.08, p< 0.05) (Figure 5A and 5B).
We also tested ceramide levels in Mfn2-/- SFOs, as
increased ceramide is reported to induce apoptosis by
activating effector caspases [25]. We found ceramide
levels in Mfn2-/- SFOs to be significantly higher (1.65 ±
0.18 vs 1 ± 0.14, p< 0.05) compared to WT (Figure 5C
and 5D).
We next assessed the expression of E-cadherin and
Connexin 37 (Cx37), key factors in oocyte-granulosa
cell communication involved in adherens and gap
junction formation, respectively. E-cadherin is
expressed exclusively in the oocyte and localized to
oocyte membrane [26]. Immunofluorescent labeling
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showed proper localization and expression of Ecadherin in WT secondary follicles while its levels were
significantly decreased in Mfn2-/- (0.45 ± 0.07 vs 1 ±
0.12, p< 0.05) (Figure 5E and 5F). Similarly, we found
significantly decreased Cx37 protein levels in Mfn2-/SFOs (0.47 ± 0.04 vs 1 ± 0.06, p< 0.01) (Figure 5G and
5H). Collectively, our findings suggest that increased
apoptosis in Mfn2-/- secondary follicle-enclosed oocytes
is associated with increased levels of ceramide in the
oocyte and impaired communication between the oocyte
and surrounding granulosa cells.
It is noteworthy that transzonal processes (TZPs), which
anchor the first layer of granulosa cells to the oocyte to
initiate gap junction formation [27], were not
significantly different in Mfn2-/- SFOs and cumulus
oocyte complexes (COCs) compared to WT
(Supplementary Figure 3A-D). In addition, the
expression of Gdf9 and Bmp15 were not significantly
changed in Mfn2-/- SFOs and GV oocytes, suggesting that
impaired follicular development was not mediated
through a decrease in these key oocyte-derived mediators
of folliculogenesis (Supplementary Figure 3E-F).
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Figure 6. The telomere is shorter in Mfn2-/- oocyte. (A) Ct values from quantitative real-time PCR (qRT-PCR) of GV oocytes,

cumulus cells and white blood cells form Mfn2-/- and WT mice. (B) Standard curves were generated by serial dilution of known amounts
of DNA to calculate relative DNA concentrations (log DNA) from Ct values of the qRT-PCR products. Orange squares, telomeres; blue
diamonds, 36B4 single copy gene control. The correlation regression equation and coefficients (R2) of Ct versus log DNA are shown. (C)
The relative telomere length of GV oocytes, cumulus cells and white blood are represented as ratio of T/S. (D) Immunofluorescence
double staining of 53BP1 (green) and TRF1 (red) in cumulus oophorus complexes of Mfn2-/- and WT mice. DAPI was used to stain nuclei
(blue). (E) Quantitative analysis of TRF1 immunofluorescence in Mfn2-/- and WT GV oocytes. The arrow showed the co-localization of
53BP1 and TRF1. Data presented as mean ± SEM. **p < 0.01, *p < 0.05 vs. WT using t-test.

Mfn2-/- GV oocytes have shortened telomeres with
decreased expression of telomere protective protein
TRF1
Mammalian telomeres consist of tandem repeats of the
sequence TTAGGG and protect the stability of
chromosomes [28]. Most cells lack telomerase, the
enzyme responsible for maintenance of telomere length,
and their telomeres shorten through consecutive cell
divisions [29]. Telomere shortening is a key mechanism
leading to cell senescence, and also has been associated
with decreased oocyte quality through disruption of
chromosome alignment and spindle structure during
meiosis [30]. As we uncovered impaired oocyte
maturation in Mfn2-/- mice and our RNAseq analysis
showed telomerase signaling pathway to be affected in
Mfn2-/- GV oocytes, we next assessed telomere length in
Mfn2-/- and WT GV oocytes using quantitative real-time
PCR [28]. Cumulus cells (CCs) and white blood cells
(WBCs) were also assessed as somatic controls.
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Telomere length of Mfn2-/- GV oocytes was significantly
shorter compared to WT, as more PCR cycles (23.68 ±
0.63 vs 20.7 ± 0.78, p< 0.05) were required to reach the
threshold (Figure 6A), and telomere/single-copy gene
ratio (T/S), a good indication of relative telomere length
[28], was lower (Figure 6B and 6C). There was no
difference in the telomere length of CCs and WBCs in
Mfn2-/- mice compared to WT (Figure 6C).
Recent studies have shown an important role for
telomeric repeat-binding factor 1 (TRF1), a molecule of
shelterin protein complex, in protecting the telomere
DNA integrity and stability [31]. Loss of TRF1 leads to
DNA damage response and accumulation of DNA
repair factors such as 53BP1 [32, 33]. To investigate
whether the shortened telomere in Mfn2-/- oocytes is
associated with decreased protection and/or accelerated
telomere damage, we performed co-immunofluorescence staining of TRF1 and 53BP1, and found TRF1 to
be significantly decreased in Mfn2-/- GV oocytes’ nuclei
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compare to WT (Figure 6D and 6E). In addition, TRF1
co-localized with 53BP1 in Mfn2-/- oocytes, indicating
telomere damage in the Mfn2-/- oocytes (Figure 6D,
shown by arrows).

DISCUSSION
In the current study, we investigated whether female
fertility is impaired in mice with oocyte-specific
targeted deletion of Mfn2, a key regulator of
mitochondrial fusion. We found that Mfn2-/- mice
produce less pups compared to WT (Figure 1A). They
also generate less mature antral follicles (Figure 4) and
less mature oocytes and embryos (Figure 1B). Our
findings demonstrate that absence of MFN2 in oocytes
results in female subfertility associated with impaired
folliculogenesis and oogenesis. Consistent with our
observations, Liu et al. had previously reported that
knockdown of Mfn2 by siRNA in immature oocytes
results in mitochondrial dysfunction and abnormal
spindle formation, and causes a decline in oocyte
maturation and fertilization [17]. Importantly, we
observed that deletion of Mfn2-/- in oocytes results in
decreased fertility, but not in a complete loss of
reproductive function. MFN2 plays a key role in
mitochondrial fusion and mitochondria-ER interactions.
Therefore, the limited (but not absent) reproductive
potential in Mfn2-/- female mice, could be explained by
compensatory effects of other proteins, such as MFN1.
We then characterized mitochondrial function,
distribution, and dynamics in Mfn2-/- oocytes, focusing
first on parameters related to mitochondrial energy
generation. We found Mfn2-/- oocytes to have lower
expression of the ETC genes and decreased ATP
production (Figure 2). Therefore, our findings support
existing data suggesting an association between
decreased oocyte ATP levels and impaired oocyte
maturation. Indeed, two peaks of ATP production have
been observed during oocyte maturation [34]. The first
one is during germinal vesicle breakdown (GVBD) and
the second one is during the extrusion of the first polar
body. Importantly, the second peak (associated with
first polar body extrusion) is absent in oocytes that fail
to complete the first meiotic division. Similarly, ATP
content of human oocytes have been linked to
developmental potential and IVF outcome [35].
Mitochondria are motile organelles and changes in
mitochondrial function have been associated with
differential cellular distribution of mitochondria [36],
with three main mitochondrial distribution patterns
described as subplasmalemmal, pan-cytoplasmic and
perinuclear [37]. Our results revealed perinuclear
aggregation of mitochondria in Mfn2-/- oocytes (Figure
2H), similar to that described in blastomeres with
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diminished ATP generating capacity [21]. When we
assessed mitochondrial size and shape (dynamics) in
Mfn2-/- oocytes by electron microscopy, we found that
Mfn2-/- mice oocytes have bigger and rounder
mitochondria (Figure 2J-L). In addition, we found
mtDNA copy number to be lower in Mfn2-/- oocytes
compared to WT (Figure 2E). This finding is in contrast
with high mtDNA copy number detected in Clppdeficient mice oocytes with severe metabolic
dysfunction and mitochondrial stress [22], and suggest
that decreased as well as increased amount of mtDNA
may be detected in oocytes with metabolic distress,
depending on the pathways involved.
After characterizing the developmental and metabolic
changes that occur in MFN2-deficient oocytes, we
performed RNAseq analysis in SFOs and GV oocytes
from Mfn2-/- and WT mice to identify genes and
pathways affected by MFN2 (Figure 3). In total, we
found 1,041 genes to be differentially expressed in
Mfn2-/- SFOs and 363 in Mfn2-/- GV oocytes compared
to WT. Of particular interest, death receptor signaling,
ceramide biosynthesis and adherens junction signaling
pathways were affected in Mfn2-/- SFOs (Figure 3H),
while aging-related telomerase and sirtuin signaling
pathways were affected in Mfn2-/- GV oocytes (Figure
3D).
The number of resting follicles available in the ovary,
also called ovarian reserve, is the primary determinant
of response to ovarian stimulation in women
undergoing infertility treatment [38]. Targeted deletion
of Mfn2 in oocytes resulted in accelerated follicular
depletion, similar to that observed in mice with global
germline deletion of mitochondrial stress response gene
Clpp, where oocytes have severe metabolic dysfunction
[22, 39]. Specifically, we found a dramatically
decreased number of primordial follicles starting at 6
months in Mfn2-/- mice, depletion of primordial follicles
and significantly decreased number of primary and
secondary follicles at 12 months, and decreased serum
AMH levels, consistent with a diminished ovarian
reserve phenotype (Figure 4). Our findings regarding
accelerated follicular depletion in Mfn2-/- mice are
supported by a previous study showing decreased
MFN2 expression in mice that develop apoptotic oocyte
loss and ovarian failure in response to cisplatin
treatment [18].
The reproductive phenotype that we observed in this
study should be interpreted within the context of the
experimental approach used for targeted deletion. Zp3driven targeted deletion in oocytes occurs only after the
follicle reaches the primary follicle stage. Therefore,
Zp3-Cre system does not allow targeted deletion in
dormant oocytes stored in primordial follicles, making
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its use challenging within the context of reproductive
aging. Alternatively, Vasa-Cre allows Cre enzyme to be
expressed in oocytes at all developmental stages
(including during fetal life and primordial follicles
before and after sexual maturation) [40]. However,
Vasa-Cre has been found to have leaky expression in
the early embryo and may cause lethality [40, 41],
limiting its use. In the current manuscript, utilization of
the Zp3-Cre system allowed reliable assessment of the
role of MFN2 in oocytes enclosed in maturing follicles.
In addition, it enabled us to conclude that accelerated
loss of primordial follicles is caused by accelerated
recruitment rather than a direct effect on these follicles
(as the Zp3-Cre system is not yet active in primordial
follicle-enclosed oocytes).
Pathological or iatrogenic insults that result in oocyte
apoptosis may accelerate follicular depletion by
inducing arrest of follicle development [22, 42]. Indeed,
inhibition of apoptotic pathways may prevent
chemotherapy-induced follicular atresia [43]. We
confirmed increased apoptotic activity in Mfn2-/- SFOs
by demonstrating higher expression of the apoptotic
effector caspase 6 (Figure 5A). Among the several
mechanisms that may result in oocyte apoptosis,
compromised oocyte-granulosa cell communication
[24] is particularly noteworthy because RNAseq
analysis identified junction signaling pathway as being
significantly affected in Mfn2-/- SFOs. Consistent with
RNAseq findings, we found expression of adherens and
gap junction proteins to be significantly decreased in
Mfn2-/- SFOs (Figure 5E-H). Ceramide, which induces
apoptosis by releasing cytochrome c from mitochondria
and activating effector caspases [25], was also elevated
in Mfn2-/- SFOs (Figure 5C), consistent with RNAseq
findings. It is noteworthy that ceramide accumulates in
aging oocytes, potentially playing a role in age-related
acceleration of follicle depletion [44]. Our findings are
consistent with previous reports suggesting that
mitochondrial fusion plays a protective role against
apoptosis [45, 46].
Reproductive aging is associated with a decline in
oocyte quality in addition to decreased number of
follicles in the ovary [47]. Telomere shortening may
contribute to impaired reproductive function and
reproductive aging as it is associated with increased
meiotic defects, spindle and chromosome abnormalities,
and embryo fragmentation [30, 48]. RNAseq analysis
uncovered telomere signaling pathway to be
significantly affected in Mfn2-/- GV oocytes, which had
shorter telomeres (Figure 6A-C), and lower expression
of telomere protective protein TRF1 (Figure 6D-F),
with increased co-localization of 53BP1 with TRF1.
These findings are in line with recent studies,
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demonstrating an essential role for mitochondria in
maintaining telomere length during aging [49].
Reactive oxygen species (ROS) generated by
mitochondria are considered major contributors to
telomeric DNA damage and may have a significant
impact on cellular senescence [49]. Increased ROS may
cause telomere damage through ineffective DNA repair
and increased mtDNA damage [50]. In the current
study, in addition to significantly increased ROS
generation, we found dramatically decreased mtDNA
copy number in Mfn2-/- oocytes compared to WT
(Figure 2). There seems to be a close relationship
between mtDNA copy number and telomere length [51,
52], and a positive correlation was also observed in a
number of disease models [53, 54]. Importantly,
mtDNA depletion in skeletal myoblasts induces
telomere shortening [52]. Our findings suggest that
targeted deletion of Mfn2 in oocytes results in
mitochondrial dysfunction, increased ROS, and lower
mtDNA content, which in turn is associated with
telomere shortening, possibly contributing to subfertility
and accelerated follicular depletion.
In this study, we uncovered that oocyte specific deletion
of Mfn2 results in female subfertility due to impaired
oocyte maturation and follicular development. In
addition, absence of Mfn2 in the oocyte results in
accelerated follicular depletion and a phenotype similar
to that observed in women with diminished ovarian
reserve. Studies are underway to delineate how intricate
interactions between metabolism, mitochondrial
function, and reproduction determine reproductive
success and failure in women through different stages of
reproductive lifespan.

MATERIALS AND METHODS
Animals
All animal care and experimental procedures were
conducted in accordance with Yale University animal
research requirements under the protocols approved by
the Institutional Animal Care and Use Committee
(protocol # 2017-11207). Mfn2flox/flox mice (stock
number 026525) and Zp3-Cre mice [19, 20] (where Cre
is driven by Zp3 promoter) in C57BL/6 background
(stock number 003651) were purchased from The
Jackson Laboratory. Mfn2flox/flox mice were crossbred
with Zp3-Cre mice to produce mice with oocytespecific Mfn2 deletion (Mfn2fl/fl/Zp3-Cre mice), and for
simplicity, they are referred to as Mfn2-/- mice hereafter.
Genotyping was carried out using the primers shown in
Supplementary Table 1.
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Assessment of fertility
To assess the fertility of Mfn2-/- female mice, seven
mating cages were set up. In each cage, one adult male
mouse (12-week-old) with proven fertility was placed
with two female mice (Mfn2-/- and WT). Male mice
were rotated every week. Fertility test was carried out
for 12 consecutive weeks. Cages were monitored daily.
Number of pups and litters were recorded.
Histomorphometric analysis of folliculogenesis in
ovaries
Ovaries from 8-week-old Mfn2-/- and WT female mice
were extracted and fixed in 4% (w/v) paraformaldehyde
in Dulbecco's phosphate buffered saline (DPBS) at
room temperature overnight, and stored at 4°C in fresh
70% ethanol until processed. Ovaries were then
dehydrated, embedded in paraffin, sectioned (5 μm),
and stained with hematoxylin and eosin (H&E). Every
fifth section on the slides were assessed, and only the
follicles that contain oocytes with clearly visible
nucleus were counted. Primordial, primary, secondary
and antral follicles were classified as described
previously [55]. Briefly, primordial follicles were
defined as an oocyte surrounded by a single layer of
squamous granulosa cells. Primary follicles possessed
an oocyte surrounded by a single layer of cuboidal
granulosa cell layer. Secondary follicles consisted of an
oocyte surrounded by two or more layers of cuboidal
granulosa cells with no visible antrum. Antral follicles
contained four or more layers of granulosa cells with a
clearly defined single antral space.
Follicle, oocyte, and embryo collection
Eight-week-old female Mfn2-/- and WT mice were used
to collect oocytes, embryos, and follicles. To collect
germinal vesicle (GV) stage oocytes, 5 IU PMSG
(Sigma, St. Louis, MO) was injected intraperitoneally
and ovaries were extracted 44-48 h after the injection.
To retrieve the oocytes, ovaries were punctured with a
26-gauge needle. Collected oocytes were placed in M2
medium (Sigma, St. Louis, MO) and 10 μM milrinone
(Sigma, St. Louis, MO) to prevent meiotic resumption.
To obtain mature oocytes, an additional injection of 5
IU of human chorionic gonadotrophin (hCG; Sigma, St.
Louis, MO) to induce oocyte maturation and ovulation
was given 48 h after the PMSG injection. Unfertilized
oocytes at metaphase of the second meiotic division
(MII) were collected from oviducts 14 h after the hCG
injection. To collect fertilized embryos, females were
mated with WT males immediately after the hCG
injection. The following morning, mating was
confirmed by the presence of a vaginal plug. Two-cell
embryos were collected 44 h after hCG injection from
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the oviducts in KSOM medium (Millipore, Darmstadt,
Germany). Blastocysts were collected 92 h after hCG
injection from uterus into M2 medium (Sigma, St.
Louis, MO). Secondary follicles were collected by
digesting the ovaries with 1.5 mg/mL collagenase type
V (Sigma, St. Louis, MO) for 1 h at 37°C in M2
medium (Sigma, St. Louis, MO) [16].
Quantification of ATP
ATP content of individual oocytes was determined
using the ATP bioluminescent somatic cell assay kit
(Sigma, St. Louis, MO). Oocytes were collected, lysed,
and stored individually in 100 µl of ATP releasing
reagent at -80ºC. ATP Assay Mix Working Solution
(100 µl, 1:25 diluted from ATP Assay Mix Stock
Solution) was added individually to 96-well plate wells
and kept at room temperature for 5 min. Fifty µl of
sample or standard to be assayed weas mixed with 50 µl
of ATP releasing reagent and shaken briskly; 100 µl of
this mix was transferred individually to the 96-well
plate containing 100 µl of ATP Assay Mix Working
Solution that was previously prepared and equilibrated,
and the amount of light emitted was measured
immediately with Dynex MLX microliter plate
luminometer (Dynex Technologies, Chantilly, VA).
ATP in single oocyte samples was calculated by
comparison to a standard curve generated over the range
2.5–500 fmol/100 µl.
Quantitative reverse-transcription polymerase chain
reaction (qRT-PCR)
Total RNA was obtained from oocytes using
RNAqueous Microkit (Thermo Fisher Scientific,
Waltham, MA) and was treated with DNase I (Thermo
Fisher Scientific) for genomic DNA contamination.
Reverse transcription was performed using the
RETROscript kit (Thermo Fisher Scientific, Waltham,
MA) in two steps: first, template RNA and random
primers were incubated at 85ºC for 3 min to eliminate
any secondary structures, and then the buffer and
enzyme were added and the reaction was carried out at
42ºC for 1 h. qRT-PCR was carried out in an iCycler
(Bio-Rad Laboratories, Hercules, CA). cDNA was
prepared as described above, and assayed in triplicates.
Each experiment was repeated at least three times using
individual animals from each genotype. Each 10-μl
reaction contained 5 μl of SYBR Green supermix (BioRad Laboratories, Hercules, CA), 3 µl of H2O, 0.5 μl of
each primer, and 1 µl of cDNA. TaqMan Gene
expression assays (Life Technologies, Carlsbad, CA)
were also used following manufacturer’s instructions.
Briefly, each 20-µl reaction contained 1 µl of 20X
TaqMan gene expression assay, 10 µl of 2X TaqMan
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Gene expression master mix, 4 µl of cDNA template,
and 5 µl of H2O. The 2-ΔΔCT (cycle threshold) method
was used to calculate relative expression levels after
normalization to Actb (β-actin) levels. The primers used
for real-time PCR reactions were included in
Supplementary Table 1.
Electron microscopic analysis
For transmission electron microscopy, 3 Mfn2-/- and 3
WT female mice were deeply anesthetized 44 h after
PMSG injection followed by perfusion of 4%
paraformaldehyde/PBS. Both ovaries were fixed at 4ºC
overnight with the fixative solution (paraformaldehyde
2%, glutaraldehyde 2.5% in cacodylate buffer 0.1 M,
pH 7.4). After ovaries were rinsed in the same buffer
twice, they were postfixed in 1% OsO4 in 0.1 M
cacodylate buffer at room temperature for 60 min.
Specimens were stained en bloc with 2% aqueous
uranyl acetate for 30 min, dehydrated in a graded series
of ethanol to 100% and embedded in Poly/bed 812
resin. Then the blocks were polymerized in a 60°C oven
for 24 h and thin sections (60 nm) were cut by a Leica
ultramicrotome and post-stained with 2% uranyl acetate
and lead citrate. Cell sections were examined with a FEI
Tecnai transmission electron microscope and digital
images were recorded with an Olympus Morada CCD
camera and iTEM imaging software. Oocytes were
imaged at 11,500X magnification. ImageJ software was
used to measure the mitochondria area, length and
width.
Analysis of mitochondrial membrane potential
Mitochondrial membrane potential was assessed by
incubating oocytes with the mitochondrial membrane
dye JC-1 (Invitrogen, Carlsbad, CA) at 2 μg/ml for 30
min at 37°C in the dark. Following the incubation, JC1-free media was used to wash the oocytes. Then
oocytes were imaged by Leica SP5 spectral scanning
confocal microscopy in green and red fluorescence
channels. For the green channel, excitation was
performed at 488 nm and emission at 530 nm. For the
red channel, excitation was performed at 568 nm and
emission at 590 nm. Quantification of the pixel intensity
was assessed by Image J software.
Determination of ROS levels
Reactive oxygen species (ROS) generation was induced
by exposing oocytes to 20 mM H2O2 for 5 min and then
measured by incubating these oocytes with 30 µM
H2DCFDA (6-carboxy-2',7’-dichlorodihydrofluorescein
diacetate, Life Technologies, Carlsbad, CA) in M2
medium for 20 min. H2DCFDA is a nonfluorescent
chemical which can pass through the plasma membrane
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and converts to green fluorescent upon oxidation with
ROS [56]. Oocytes were washed three times in
H2DCFDA-free media before imaging using Leica SP5
spectral scanning confocal microscope. ImageJ software
was used to quantify fluorescence.
Quantification of mtDNA copy number in oocytes
To quantify mtDNA levels in individual oocytes, Cox3
fragment was amplified using the primers shown in
Supplementary Table 1 and subcloned into pCR™2.1TOPO® - cloning vector (Invitrogen, Carlsbad, CA) as
previously described [57]. One Shot TOP10 Chemically
Competent E. coli were transformed and grown
overnight at 37ºC. Recombinant plasmids were purified
using Qiagen plasmid isolation kit and the inserted
mtDNA fragment was confirmed by DNA sequence
analysis. Plasmid DNA was quantified using NanoDrop
2000 spectrophotometer (Thermo Scientific, Waltham,
MA). A standard curve from 108 to 101 plasmid
molecules was generated by serial 10-fold dilutions.
Single oocytes from Mfn2-/- and WT mice were
individually lysed in 10 µl lysis solution containing 125
µg/ml Proteinase K and 17 µM SDS in sterile water by
incubating at 55ºC for 2 h. Then, proteinase K was
inactivated by heating the lysis mix at 95ºC for 10 min
and the mix was used directly for downstream PCR.
Reactions were performed in triplicates. Each 10 µl
reaction contained 5 µl of SYBR Green supermix (BioRad Laboratories, Hercules, CA), approximately 0.3
μM of each primer, and 1/3 of oocyte’s total DNA.
Each individual oocyte’s mtDNA copy number was
extrapolated from the standard curve.
Immunostaining of oocyte spindles
To stain the spindles, oocytes were fixed in 4% (w/v)
paraformaldehyde in DPBS (pH 7.4) for 30 min, and
permeabilized in 0.5% Triton X-100 for 5 min. Then,
oocytes were incubated with 2 μg/ml anti-α-Tubulin
(Millipore, Billerica, MA) for 1 h, washed three times
for 5 min in DPBS and stained with 4’,6-diamidino-2phenylindole (DAPI, Life Technologies, ThermoFisher
Scientific, Waltham, MA) prior to being examined
using Leica SP5 spectral scanning confocal microscope
(Leica Microsystem, Buffalo Grove, IL) using
excitation at 488 nm and emission at 530 nm (αTubulin), and excitation at 350 nm and emission at 470
nm (DAPI).
Staining of transzonal processes
Cumulus oocyte complexes (COCs) and secondary
follicle enclosed oocytes (SFOs) were collected and
fixed in 2% formaldehyde (Sigma, St. Louis, MO) for 1
h at 37°C, then washed in phosphate buffered saline
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with 0.1% Triton X-100 and 0.01% PVA and blocked
with 3% BSA for 30 min at room temperature.
Rhodamine-phalloidin (Life Technologies, Carlsbad,
CA) diluted 1:40 in PBS/PVA was used to label the Factin TZPs. In the last step, follicles were washed three
times in PBS/PVA. Then oocytes were imaged by Leica
SP5 spectral scanning confocal microscopy.
Immunofluorescence staining
To perform immunofluorescence staining on paraffin
embedded tissues, paraffin wax was removed by heating
the slides for 45 min at 65°C. Tissue sections were then
rehydrated with xylene and 100% ethanol. To retrieve
antigens, slides were incubated with sodium citrate
buffer (10 mM, pH 6.0) in a pressure cooker for 1 h.
Slides were then cooled down to 27°C, and treated with
0.5% Triton X-100 for 10 min to permeabilize the
tissue. To block the non-specific binding, slides were
incubated in 2% Bovine Serum Albumin (BSA) for 45
min. Following the washing steps, slides were incubated
overnight at 4°C with primary antibodies for Ecadherin, Connexin 37, Caspase-6 (Santa Cruz
Biotechnology, Dallas, TX) or Ceramide (Enzo Life
Sciences, Farmingdale, NY) diluted 1:50. The next day,
slides were washed in 0.5% BSA diluted in PBS and
incubated for 60 min at room temperature with Alexa
Fluor 594-conjugated or Alexa Fluor 488-conjugated
secondary antibodies (Thermo Fisher Scientific,
Waltham, MA) diluted 1:200. Slides were then
incubated
with
4’,
6-diamidino-2-phenylindole
(DAPI;1:1000) (Life Technologies, Carlsbad, CA) and
stored at 4°C until imaging.
To perform immunofluorescent staining on oocytes,
they were collected and fixed with 4% paraformaldehyde (Sigma, St. Louis, MO) in DPBS for 5 min, placed
in 0.5% Triton X-100 in DPBS at room temperature for
30 min, followed by three times wash in DPBS. After
blocking in 3% BSA (Sigma, St. Louis, MO) at room
temperature for 1h, oocytes were incubated overnight at
4°C with mouse anti-TRF1 monoclonal antibody
(Abcam, Cambridge, UK) and rabbit anti-53BP1
monoclonal antibody (Cell Signaling Technology,
Danvers, MA). After three washes with DPBS, oocytes
were incubated with Alexa Fluor 594-conjugated goat
anti-rabbit antibody and Alexa Fluor 488-conjugated
goat anti-mouse antibody for 1h at room temperature.
For Mito-tracker and ER-tracker staining, oocytes were
collected, fixed and then labeled with MitoTracker Red
CMXRos (Invitrogen, Carlsbad, CA) and ER-Tracker
Blue (Invitrogen, Carlsbad, CA) for 30 min at 37°C,
washed with DPBS and mounted on glass slides.
Images were captured on Leica SP5 spectral scanning
confocal microscope and Image J software was used to
quantify the fluorescence intensity.
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AMH and FSH testing
To measure the serum levels of Anti-Mullerian
hormone (AMH) and follicle stimulating hormone
(FSH), samples were sent to University of Virginia
Center for Research in Reproduction Ligand Assay and
Analysis Core, where ANSH ELISA kit was used to
measure AMH levels, in-house RIA (radioimmunoassay) was used to measure FSH.
RNA sequencing and data analysis
Five secondary follicle enclosed oocytes and GV
oocytes each collected from Mfn2-/- or WT mice (n=3)
were pooled, respectively, and cDNA was amplified
using Smart-Seq2 protocol as previously described [58,
59]. Briefly, oocytes were lysed and mRNA was
captured and amplified by using Smart-seq2 v4 kit
(Clontech). After pre-amplification and AMPure XP
beads purification, amplified RNAs were quality
checked using Agilent High Sensitivity D5000 kit
(Agilent Technologies). RNA sequencing libraries were
constructed using Nextera® XT DNA Library
Preparation Kit (Illumina, San Diego, CA) and
multiplexed using Nextera® XT Index Kit (Illumina,
San Diego, CA). Libraries were quantified by Qubit and
Tapestation 4200. Indexed libraries were then pooled
and sequenced on Illumina’s Hiseq 2500 platform with
100 bp pair-end reads. In total, we analyzed 12 samples
and obtained approximately 212 million reads. The raw
FASTQ files and normalized read counts are available
at
Gene
Expression
Omnibus
(GEO)
(http://www.ncbi.nlm.nih.gov/geo) under the accession
number (GSE128842).
For RNAseq data analysis, multiplexed sequencing
reads that passed filters were trimmed to remove
adapters using Cutadapt and low quality reads were prefiltered by FASTX-Toolkit before mapping. Clean reads
were aligned to the mouse genome (GRCm38/mm10)
using STAR with default parameters. Individual
mapped reads were quantified to annotation model to
calculate gene counts. Differential expression analysis
between Mfn2-/- or WT groups was performed using
Partek Flow GSA algorithm with default parameters.
Differentially expressed genes between Mfn2-/- and WT
groups were determined using false discovery rate
(FDR) of p value < 0.05, foldchange > 2 and a minimal
of 5 reads as cutoffs. Cluster analyses were performed
by the K-means clustering algorithm using R. DAVID
and Ingenuity Pathway Analysis (IPA) software were
used to perform Gene Ontology (GO) and pathways
analyses, respectively.
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Telomere length measurement
Approximately 20 oocytes and their surrounding
cumulus cells were collected respectively and stored at
–80 ºC until use. DNA was extracted from oocytes and
cumulus cells using QIAmp DNA micro Kit
(Qiagen,Valencia, CA) and quantified. Approximately
0.5 ml blood sample were collected form each group of
mice and blood DNA was extracted using DNA
isolation kit for mammalian blood (Roche, Basel,
Switzerland). Average telomere length was measured
from total genomic DNA using a real-time PCR assay,
as previously described [28]. Telomeric primers and
primers for the control gene (mouse 36B4 single copy
gene) are listed in Supplementary Table 1. For each
PCR reaction, a standard curve was generated by serial
dilutions of known amounts of DNA from the same
tissues. The telomere signal was normalized to the
signal from the single-copy gene to generate T/S ratio.
The relative telomere length is indicated by T/S ratio.
Statistical analysis
Quantitative data are expressed as mean ± SEM.
Student’s t-test was used to analyze the statistical
significance between two groups. Data are
representative of at least three independent experiments
unless otherwise specified. All statistical analyses were
done using Graph Pad Prism software version 7 and
significance was assessed at p < 0.05.
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SUPPLEMENTARY MATERIAL
Supplementary Figures

Supplementary Figure 1. Serum AMH and FSH levels in female Mfn2-/- mice. (A, B) Serum FSH and AMH levels in 2, 6- and 12
months old female WT and Mfn2-/- mice. Data presented as mean ± SEM. *p < 0.05, **p < 0.01 vs. WT from t-test.

Supplementary Figure 2. Ovarian size is decreased in Mfn2-/- mice. (A) Representative photographs of ovaries from 8-weekold Mfn2-/- and WT mice. (B) Mfn2-/- mice had significantly smaller ovaries. Data presented as mean ± SEM. **p < 0.01 vs. WT
from t-test.
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Supplementary Figure 3. TZP formation is not changed in Mfn2-/- secondary follicles of COCs. (A, C) Secondary follicles and
COCs were isolated from the ovaries of Mfn2-/- and WT mice, fixed, labeled with rhodamine-phalloidin, and examined by
confocal microscopy. Asterisk designates oocyte; open arrow designates labeling of TZPs. (B, D) The total peak intensity for
the zona pellucida and plasma membrane was calculated. (E, F) qRT-PCR analysis of Gdf9 and Bmp15 expression in Mfn2-/and WT SFOs and GV stage oocytes. Data presented as mean ± SEM.
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Supplementary Table
Table S1. The list of primers used for quantitative RT-PCR
Gene

TaqMan assay number or Primer sequences
(5' to 3'; F, forward; R, reverse)

β-actin

Mm00607939_s1

β-actin

F: GGCTGTATTCCCCTCCATCG
R: CCAGTTGGTAACAATGCCATGT

Atp5a1

Mm00431960_m1

Bmp15

Mm00437797_m1

activin-β

F: AGATCCCGCACCTCGAC
G: TGGTTGCCTTCATTAGAGACG

Cox1

Mm04225243_g1

Cox3

F: TTTGCAGGATTCTTCTGAGC
R: TGAGCTCATGTAATTGAAACACC

Cre

F: ATGCTTCTGTCCGTTTGCC
R: CAACACCATTTTTTCTGACCC

Dnaja3

Mm00469723_m1

Gdf9

Mm00434083_m1

Hspd1

F: AGTGGATGACCTCGTGTTATGC
R: GGATCTAGTTTCTGGCCTCTTCG

Hspe1

F: TGGTAATCTTTAGCGGTGCTC
R: GGAGGACTTTATCCCACAGC

Mfn2 flox

F: GAAGTAGGCAGTCTCCATCG
R: AACATCGCTCAGCCTGAACC

Ndufv1

Mm00504941_m1

Sdhb

Mm00458272_m1

Uqcrc2

Mm00445961_m1

Telomeric

F: CGG TTT GTT TGG GTT TGG GTT TGG GTT TGG GTT TGG GTT
R: GGC TTG CCT TAC CCT TAC CCT TAC CCT TAC CCT TAC CCT

36B4 control

F: ACT GGT CTA GGA CCC GAG AAG
R: TCA ATG GTG CCT CTG GAG ATT

Abbreviations: Atp5a1: ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1; Bmp15: bone
morphogenetic protein 15; Cox1: cytochrome c oxidase subunit I; Cox3: cytochrome c oxidase subunit III; Drp1: Dynamin
related protein 1; Gdf9: growth differentiation factor 9; Mfn2: mitofusin 1; Ndufv1: NADH dehydrogenase (ubiquinone)
flavoprotein 1; Opa1: mitochondrial dynamin like GTPase; Sdhb: succinate dehydrogenase complex iron sulfur subunit B;
Uqcrc2: ubiquinol cytochrome c reductase core protein 2.
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